Table 2. Inter-relationship among Masaoka stage, WHO histology and MG.
Subgroups | Masaoka stage | P value | MG | P value | ||||
---|---|---|---|---|---|---|---|---|
I | II | III | IV | + | − | |||
WHO histology | <0.001 | 0.034 | ||||||
A | 7 | 4 | 3 | 0 | 3 | 12 | ||
AB | 16 | 7 | 4 | 2 | 10 | 19 | ||
B1 | 11 | 7 | 4 | 2 | 7 | 17 | ||
B2 | 1 | 3 | 4 | 2 | 6 | 4 | ||
B3 | 2 | 1 | 3 | 5 | 2 | 9 | ||
C | 0 | 1 | 8 | 9 | 1 | 17 | ||
MG | 0.12 | − | ||||||
+ | 15 | 14 | 8 | 4 | − | − | ||
− | 33 | 18 | 27 | 20 | − | − |
WHO, World Health Organization; MG, myasthenia gravis.